Your browser doesn't support javascript.
loading
RNA m6 A methylation regulates sorafenib resistance in liver cancer through FOXO3-mediated autophagy.
Lin, Ziyou; Niu, Yi; Wan, Arabella; Chen, Dongshi; Liang, Heng; Chen, Xijun; Sun, Lei; Zhan, Siyue; Chen, Liutao; Cheng, Chao; Zhang, Xiaolei; Bu, Xianzhang; He, Weiling; Wan, Guohui.
Affiliation
  • Lin Z; Department of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Niu Y; National-Local Joint Engineering Laboratory of Druggability and New Drug Evaluation, National Engineering Research Center for New Drug and Druggability (cultivation), Guangdong Province Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University, G
  • Wan A; National-Local Joint Engineering Laboratory of Druggability and New Drug Evaluation, National Engineering Research Center for New Drug and Druggability (cultivation), Guangdong Province Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University, G
  • Chen D; Department of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Liang H; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • Chen X; National-Local Joint Engineering Laboratory of Druggability and New Drug Evaluation, National Engineering Research Center for New Drug and Druggability (cultivation), Guangdong Province Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University, G
  • Sun L; Department of Abdominal Surgery, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.
  • Zhan S; National-Local Joint Engineering Laboratory of Druggability and New Drug Evaluation, National Engineering Research Center for New Drug and Druggability (cultivation), Guangdong Province Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University, G
  • Chen L; National-Local Joint Engineering Laboratory of Druggability and New Drug Evaluation, National Engineering Research Center for New Drug and Druggability (cultivation), Guangdong Province Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University, G
  • Cheng C; School of Life Science, Sun Yat-Sen University, Guangzhou, China.
  • Zhang X; Department of Thoracic Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Bu X; National-Local Joint Engineering Laboratory of Druggability and New Drug Evaluation, National Engineering Research Center for New Drug and Druggability (cultivation), Guangdong Province Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University, G
  • He W; National-Local Joint Engineering Laboratory of Druggability and New Drug Evaluation, National Engineering Research Center for New Drug and Druggability (cultivation), Guangdong Province Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-Sen University, G
  • Wan G; Department of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
EMBO J ; 39(12): e103181, 2020 06 17.
Article in En | MEDLINE | ID: mdl-32368828

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autophagy / RNA, Messenger / RNA, Neoplasm / Adenosine / Carcinoma, Hepatocellular / Drug Resistance, Neoplasm / Forkhead Box Protein O3 / Sorafenib / Liver Neoplasms / Neoplasm Proteins Limits: Animals / Humans / Male Language: En Journal: EMBO J Year: 2020 Document type: Article Affiliation country: China Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autophagy / RNA, Messenger / RNA, Neoplasm / Adenosine / Carcinoma, Hepatocellular / Drug Resistance, Neoplasm / Forkhead Box Protein O3 / Sorafenib / Liver Neoplasms / Neoplasm Proteins Limits: Animals / Humans / Male Language: En Journal: EMBO J Year: 2020 Document type: Article Affiliation country: China Country of publication: United kingdom